News
Robles BioCeutics Welcomes Experienced Drug Developer Dr. Radu Pislariu to Scientific Advisory Board
Robles BioCeutics' lead product, GlowSelle™ is a patent-pending regenerative formulation based on molecules and exosomes released from proprietary stem cells that are activated using the Company's ...
A U.S. federal judge on Monday confirmed a $3.7 billion offer by Contrarian Funds' affiliate Red Tree Investments as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback